0069-0238 : Ruxience 100 mg/10ml Intravenous Injection, Solution


NDC0069-0238
Labeler: Pfizer Laboratories Div Pfizer Inc
Product Type: Human Prescription Drug
Drug Name:  Ruxience
Dosage Form: Intravenous Injection, Solution
Application #: BLA761103
Rev. Date: 


NDC Package Codes:

  • 0069-0238-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (0069‑0238‑01) > 10 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Rituximab

Dosage Strength:

  • 100 mg/10mL

Pharmaceutical Classes:

  • CD20-directed Antibody Interactions [MoA]
  • CD20-directed Cytolytic Antibody [EPC]

Related Products:

Based on records with the same trade name.
  • 0069-0249 Ruxience 500 mg/50ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0069-0238 QR Code

< Prev: 0069-0234Next: 0069-0242 >

Related Discussions:

rituximab for rheumatoid arthritis
i am 62 yr old , suffering from rheumatoid arhtritis for the past 20 years.underwent knee replacement for both legs in 2... 1 reply
Rituximab
RITUXIMAB) BY REDDY LAB.How effective is it for treatment of follicular lymphoma..The side effects.What is the cost of t... 1 reply




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.